A strategy for determining the pathogenesis of systemic sclerosis. Is transforming growth factor beta the answer?
Leroy
E C
EC
Department of Medicine, Medical University of South Carolina, Charleston.
Smith
E A
EA
Kahaleh
M B
MB
Trojanowska
M
M
Silver
R M
RM
D006801:Humans; D010982:Platelet-Derived Growth Factor / Q000378:metabolism / Q000502:physiology; D012595:Scleroderma, Systemic / Q000209:etiology* / Q000378:metabolism / Q000503:physiopathology; D015291:Transforming Growth Factors / Q000502:physiology*; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism / Q000502:physiology
D010982:Platelet-Derived Growth Factor; D014409:Tumor Necrosis Factor-alpha; D015291:Transforming Growth Factors